In the political debate over the use of embryonic stem cells, some opponents claim that malleable adult cells can take the place of their embryonic cousins. But many scientists, including those who work with adult stem cells, aren9t so sure. For some diseases, they say, adult cells may indeed turn out to be the better choice, but for other applications, embryo-derived cells have some distinct advantages.
No takes yet. Share an insight, caveat, or question.
Gretchen Vogel (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: